These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20662956)

  • 1. The quality of warfarin prescribing and monitoring in Veterans Affairs nursing homes.
    Aspinall SL; Zhao X; Handler SM; Stone RA; Kosmoski JC; Libby EA; Francis SD; Goodman DA; Roman RD; Bieber HL; Voisine JM; Jeffery SM; Hepfinger CA; Hagen DG; Martin MM; Hanlon JT
    J Am Geriatr Soc; 2010 Aug; 58(8):1475-80. PubMed ID: 20662956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of a warfarin communication protocol for nursing homes: an SBAR-based approach.
    Field TS; Tjia J; Mazor KM; Donovan JL; Kanaan AO; Harrold LR; Reed G; Doherty P; Spenard A; Gurwitz JH
    Am J Med; 2011 Feb; 124(2):179.e1-7. PubMed ID: 21295198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States.
    Baker WL; Cios DA; Sander SD; Coleman CI
    J Manag Care Pharm; 2009 Apr; 15(3):244-52. PubMed ID: 19326955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review.
    Verhovsek M; Motlagh B; Crowther MA; Kennedy C; Dolovich L; Campbell G; Wang L; Papaioannou A
    BMC Geriatr; 2008 Jul; 8():13. PubMed ID: 18598364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes associated with warfarin time in therapeutic range among US veterans with nonvalvular atrial fibrillation.
    Liu S; Li X; Shi Q; Hamilton M; Friend K; Zhao Y; Horblyuk R; Hede S; Shi L
    Curr Med Res Opin; 2018 Mar; 34(3):415-421. PubMed ID: 28945114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.
    Hylek EM; Chang YC; Skates SJ; Hughes RA; Singer DE
    Arch Intern Med; 2000 Jun; 160(11):1612-7. PubMed ID: 10847254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.
    Pokorney SD; Holmes DN; Thomas L; Fonarow GC; Kowey PR; Reiffel JA; Singer DE; Freeman JV; Gersh BJ; Mahaffey KW; Hylek EM; Naccarelli GV; Ezekowitz MD; Piccini JP; Peterson ED;
    JAMA Cardiol; 2019 Aug; 4(8):756-764. PubMed ID: 31268487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic.
    Ghaswalla PK; Harpe SE; Tassone D; Slattum PW
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):352-60. PubMed ID: 23089199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dementia and risk of adverse warfarin-related events in the nursing home setting.
    Tjia J; Field TS; Mazor KM; Donovan JL; Kanaan AO; Reed G; Doherty P; Harrold LR; Gurwitz JH
    Am J Geriatr Pharmacother; 2012 Oct; 10(5):323-30. PubMed ID: 23063288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating warfarin management by pharmacists in a community teaching hospital.
    Chilipko AA; Norwood DK
    Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
    Schultz KT; Bungard TJ
    Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratio.
    Banet GA; Waterman AD; Milligan PE; Gatchel SK; Gage BF
    Chest; 2003 Feb; 123(2):499-503. PubMed ID: 12576372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin: implementing its safe use in hospitalized patients from nursing homes and community through a performance improvement initiative.
    Dharmarajan TS; Gupta A; Baig MA; Norkus EP
    J Am Med Dir Assoc; 2011 Sep; 12(7):518-23. PubMed ID: 21450178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada.
    McAlister FA; Wiebe N; Hemmelgarn BR
    BMJ Open; 2018 Jan; 8(1):e016980. PubMed ID: 29382672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose adjustment versus no adjustment of warfarin in stably anticoagulated patients with an occasional international normalized ratio (INR) out of range.
    Schulman S; Melinyshyn A; Ennis D; Rudd-Scott L
    Thromb Res; 2010 May; 125(5):393-7. PubMed ID: 19640572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of warfarin management in primary care: Determining the stability of international normalized ratios using a nationally representative prospective cohort.
    Liu S; Singer A; McAlister FA; Peeler W; Heran BS; Drummond N; Manca DP; Allan GM; Korownyk C; Kolber MR; Greiver M; Garrison SR
    Can Fam Physician; 2019 Jun; 65(6):416-425. PubMed ID: 31189630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian dose-individualization method for warfarin.
    Wright DF; Duffull SB
    Clin Pharmacokinet; 2013 Jan; 52(1):59-68. PubMed ID: 23329393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacin.
    Mathews S; Cole J; Ryono RA
    Pharmacotherapy; 2006 Oct; 26(10):1446-52. PubMed ID: 16999655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reexamining the recommended follow-up interval after obtaining an in-range international normalized ratio value: results from the Veterans Affairs study to improve anticoagulation.
    Rose AJ; Ozonoff A; Berlowitz DR; Ash AS; Reisman JI; Hylek EM
    Chest; 2011 Aug; 140(2):359-365. PubMed ID: 21310837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.